688117 Share Price Performance
CN¥38.80
22.53 (138.45%)
Price CN¥38.80
Share Pricen/a
ChengDu ShengNuo Biotec Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
688117 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
ChengDu ShengNuo Biotec Co.,Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 24, 2026
- 1.05
- 100.00%
- 22.37%
- 55.1%
About 688117
- Founded
- 2001
- Employees
- 1450
- CEO
- WebsiteView website
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.
